The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

The judge said the government has undermined its history of recognizing the importance of involving independent experts in ...

A key U.S. federal vaccine advisory ​panel has dropped a push against COVID mRNA ‌vaccines, the Washington Post reported on Wednesday, citing two people familiar with the matter.

A lawmaker compared getting the vaccine with using meth. The Idaho Medical Association said his bill would infringe on ...

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in Annals ...